Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (Weighted Average) (2017 - 2025)

Catheter Precision (VTAK) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $875627.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 711.13% to $875627.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $875627.0, a 711.13% increase, with the full-year FY2024 number at $3.3 million, up 493.91% from a year prior.
  • Shares Outstanding (Weighted Average) was $875627.0 for Q3 2025 at Catheter Precision, down from $12.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q3 2022 to a low of $90.0 in Q3 2021.
  • A 5-year average of $114.6 million and a median of $875627.0 in 2025 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 99.99% in 2021, then surged 1213598788.89% in 2022.
  • Catheter Precision's Shares Outstanding (Weighted Average) stood at $101000.0 in 2021, then surged by 923.59% to $1.0 million in 2022, then plummeted by 46.85% to $549507.0 in 2023, then skyrocketed by 493.91% to $3.3 million in 2024, then crashed by 73.17% to $875627.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Shares Outstanding (Weighted Average) are $875627.0 (Q3 2025), $12.3 million (Q2 2025), and $11.3 million (Q1 2025).